The Beauty Health Company (NASDAQ:SKIN) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET

Company Participants

Eduardo Rodriguez - Senior Director of M&A and Investor Relations

Andrew Stanleick - President & Chief Executive Officer

Liyuan Woo - Chief Financial Officer

Conference Call Participants

Maggie Boeye - William Blair

Steph Wissink - Jefferies

Oliver Chen - Cowen and Company

Olivia Tong - Raymond James

Korinne Wolfmeyer - Piper Sandler

Jon Block - Stifel

Allen Gong - JPMorgan

Bruce Jackson - The Benchmark Company

Kyle Rose - Canaccord Genuity

Linda Bolton-Weiser - D.A. Davidson

Amit Hazan - Goldman Sachs

Operator

Good morning, and welcome to Beauty Health Corp.'s 2022 Earnings Call. [Operator Instructions] Please note that this event is being recorded.

I’d like to turn the call over to Mr. Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead, sir.

Eduardo Rodriguez

Thank you, operator, and good morning, everyone. Thank you for joining The Beauty Health Company's conference call to discuss the company's second quarter 2022 financial results, which were released this morning and can be found on our website at beautyhealth.com. Also available on our website is an investor presentation that will be referenced during this call. With me on the call today are Beauty Health's President and Chief Executive Officer, Andrew Stanleick; and Chief Financial Officer, Liyuan Woo.

Before we get started, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC. This call will contain non-GAAP financial measures, such as adjusted gross margin and adjusted EBITDA. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are included in the earnings release furnished to the SEC and available on our website.

I will now turn the call over to Andrew Stanleick, President and Chief Executive Officer of The Beauty Health Company.

Andrew Stanleick

Thank you, Eduardo. Good morning, everyone, and thank you for joining our second quarter earnings call. I'm excited to walk you through our spectacular second quarter performance as well as the strong progress we have made on our strategic master plan. Before we begin, I want to welcome Marla Beck, who joined our Board of Directors in June. As the founder of Bluemercury, Marla brings invaluable beauty industry, D2C and retail experience to our Board and her positive impact is already felt.